Abstract Number: 620 • 2016 ACR/ARHP Annual Meeting
Clinical Activity, Ultrasound Assessment and Drug Monitoring in Rheumatoid Arthritis Patients Receiving Anti-TNF-α Therapy with Extended Interval of Administration
Background/Purpose: To assess clinical activity, ultrasound synovitis and drug levels in rheumatoid arthritis (RA) patients receiving anti-TNFα therapy with extended interval of administration (EIA). Methods:…Abstract Number: 1485 • 2016 ACR/ARHP Annual Meeting
Generation of New Carotid Plaque Is Determined By the Prexisting Carotid Atherosclerosis and Ongoning Disease Activity of Rheumatoid Arthritis
Background/Purpose: This study shows that carotid plaque at year 5 is predicted by IMT and dyslipidemia at baseline, whereas formation of new plaques after…Abstract Number: 441 • 2015 ACR/ARHP Annual Meeting
Ultrasound Assessment of Early Response to Certolizumab Pegol Can Predict Future Response in Patients with Rheumatoid Arthritis
Background/Purpose: Certolizumab pegol (CZP) is a PEGylated Fab’ fragment of a humanized anti-TNF antibody with high affinity to TNF. It brings rapid improvement of the…Abstract Number: 516 • 2015 ACR/ARHP Annual Meeting
Immunological and Ultrasound Characteristics of Patients with Rheumatoid Arthritis in Clinical Remission – Can We Use These to Predict Outcomes?
Background/Purpose: Remission is the key treatment goal in rheumatoid arthritis (RA). Although clinical remission is increasingly achieved, many patients progress both structurally and functionally. We…Abstract Number: 549 • 2015 ACR/ARHP Annual Meeting
Calprotectin (MRP8/MRP14), a Major Leukocyte Protein, Is Highly Associated to Ultrasound Detected Synovitis and Is Responsive to Biologic Treatment
Background/Purpose: Calprotectin (MRP8/MRP14, S100A8/A9) is a protein abundant in cytosol of granulocytes and monocytes/macrophages and released during cell activation. It reflects clinical disease activity in…Abstract Number: 1536 • 2015 ACR/ARHP Annual Meeting
Sensorineural Hearing Impairment and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients without Traditional Cardiovascular Risk Factors
Background/Purpose: Rheumatoid arthritis (RA) is characterized by inflammation of the synovial membrane of the diarthrodial joints which include arthrodesis of the middle ear, (incudomalleolar and…Abstract Number: 2686 • 2015 ACR/ARHP Annual Meeting
No Clear Association Between the Presence of Ultrasound Synovitis and Patient Reported Outcomes in Rheumatoid Arthritis Patients in Remission
Background/Purpose: Several studies assessed disease activity with ultrasound in rheumatoid arthritis (RA) patients who were in clinical remission. These studies found ultrasound synovitis in 48-73%…Abstract Number: 2691 • 2015 ACR/ARHP Annual Meeting
Musculoskeletal Ultrasound in Multi-Center Rheumatoid Arthritis Clinical Trials: Methodology for Optimizing Reliability of Acquisition and Real-Time Scoring
Background/Purpose: Rheumatoid arthritis (RA) musculoskeletal ultrasound (MSUS) literature reports good reliability of scoring still images with training, but inconsistent reliability of scoring during acquisition, likely…Abstract Number: 154 • 2015 ACR/ARHP Annual Meeting
Clinical Features of Fibromyalgia in Patients with Rheumatoid Arthritis Predict Lower Power Doppler Scores on Ultrasound
Background/Purpose: Up to 20% of patients with RA have coexisting fibromyalgia(FM). This can make treatment decisions challenging in clinical practice as disease activity scores can…Abstract Number: 156 • 2015 ACR/ARHP Annual Meeting
Usefulness of the Stricter Remission Criteria for Assessing the Absence of Subclinical Activity in Rheumatoid Arthritis
Background/Purpose: It has been seen that patients with rheumatoid arthritis (RA) who achieve remission measured by DAS28 persist with subclinical synovitis in hands and toes when…Abstract Number: 157 • 2015 ACR/ARHP Annual Meeting
Agreement Between DAS28, ACR/EULAR, SDAI, CDAI and Ultrasound Remission in Patients with Rheumatoid Arthritis Receiving Biological Treatment in Routine Care
Background/Purpose: Different remission criteria are available for patients with rheumatoid arthritis (RA). None of the criteria includes imaging remission, even though studies have shown that…Abstract Number: 164 • 2015 ACR/ARHP Annual Meeting
Subclinical Ankle Involvement in Rheumatoid Arthritis. a Multicentre Ultrasound Study
Background/Purpose: Ankle involvement is frequent in rheumatoid arthritis (RA), with at least 90% of patients affected anytime during the disease course though ankle involvement may…Abstract Number: 166 • 2015 ACR/ARHP Annual Meeting
Validity and Sensitivity to Change of the Semi-Quantitative Omeract Ultrasound Scoring System for Tenosynovitis in Patients with Rheumatoid Arthritis
Background/Purpose: Tenosynovitis is frequent in rheumatoid arthritis (RA) patients. One study indicates that tenosynovitis detected by modern imaging has prognostic value with respect to subsequent…Abstract Number: 169 • 2015 ACR/ARHP Annual Meeting
Ultrasonographic Signs of Inflammation of Metatarsophalangeal Joints in Rheumatoid Arthritis Patients Who Are Treated to Target
Background/Purpose: The feet are often involved in rheumatoid arthritis (RA), but physical examination of the metatarsophalangeal (MTP) joints to detect arthritis is challenging especially in…Abstract Number: 170 • 2015 ACR/ARHP Annual Meeting
Relationship Between Finger Joint Cartilage Evaluated By Ultrasound and Clinical Characteristics in Rheumatoid Arthritis (RA)
Background/Purpose: Joint destruction is the primary lesion by bone and cartilage damage in RA. By X-ray examination, cartilage destruction is evaluated as a joint space…
ACR Meeting Abstracts